MiR-297 inhibits tumour progression of liver cancer by targeting PTBP3
暂无分享,去创建一个
[1] Yongxin Zhou,et al. PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma , 2022, Cell cycle.
[2] L. Shang,et al. New Insights Into PTBP3 in Human Cancers: Immune Cell Infiltration, TMB, MSI, PDCD1 and m6A Markers , 2022, Frontiers in Pharmacology.
[3] Luyang Yu,et al. Human Amniotic Epithelial Stem Cells: A Promising Seed Cell for Clinical Applications , 2020, International journal of molecular sciences.
[4] Xuefeng Cao,et al. Investigation of microRNA expression signatures in HCC via microRNA Gene Chip and bioinformatics analysis. , 2020, Pathology, research and practice.
[5] C. Peng,et al. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..
[6] Jianwen Liu,et al. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells , 2017, British Journal of Cancer.
[7] Y. Akao,et al. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells , 2017, International journal of molecular sciences.
[8] Xiangkun Yuan,et al. miR‐297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma , 2016, Cell proliferation.
[9] Amit G Singal,et al. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] Xiu-li Wang,et al. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7 , 2015, Oncotarget.
[11] Qiuwan Zhang,et al. Human amniotic epithelial cells inhibit granulosa cell apoptosis induced by chemotherapy and restore the fertility , 2015, Stem Cell Research & Therapy.
[12] Dequan Wu,et al. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. , 2015, Biochemical and biophysical research communications.
[13] Chuan Chen,et al. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy. , 2015, World journal of hepatology.
[14] Jian-wen Liu,et al. The effects of PTBP3 silencing on the proliferation and differentiation of MKN45 human gastric cancer cells. , 2014, Life sciences.
[15] B. Kefas,et al. A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival. , 2013, Neuro-oncology.
[16] L. Qin,et al. miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma , 2013, The Journal of experimental medicine.
[17] K. Aldape,et al. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis. , 2012, Molecular cell.
[18] S. Lowe,et al. The microcosmos of cancer , 2012, Nature.
[19] J. Li,et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 , 2012, Oncogene.
[20] W. Yeo,et al. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. , 2011, Future oncology.
[21] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[22] W. Filipowicz,et al. The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.
[23] M. Bushell,et al. Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1 , 2010, Oncogene.
[24] J. Coon,et al. Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro , 2007, Oncogene.
[25] H. Niknejad,et al. Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy. , 2014, Cytotherapy.